Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Measuring Reticulocyte Hemoglobin Content As a Marker for Iron Deficiency and Response to Therapy Represents a Paradigm Shift in Care

Michael Auerbach, MD, Carlo Brugnara, MD, Steve Staffa, PhD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-134693

Published: 2020

Journal Articles

The Safety and Efficacy of Ferumoxytol in the Treatment of Iron Deficiency: A Systematic Review and Meta-Analysis

Jameel Abdulrehman, MD, Grace Tang, MSc, Michael Auerbach, MD, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2018) 132 (Supplement 1): 4894.

https://doi.org/10.1182/blood-2018-99-114146

Published: 2018

Journal Articles

A Single Infusion of Iron Isomaltoside 1000 Allows a More Rapid Hemoglobin Increment Than Multiple Doses of Iron Sucrose with a Similar Safety Profile in Patients with Iron Deficiency Anemia

Michael Auerbach, MD, Lars L Lykke, MD PhD

Blood (2018) 132 (Supplement 1): 2334.

https://doi.org/10.1182/blood-2018-99-110199

Published: 2018

Journal Articles

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Michael Auerbach, MD, William E Strauss, MD, Iain C. Macdougall, MD, Kristine Bernard, MPH, Robert F Kaper, MD, Glenn M Chertow, MD MPH, Zhu Li, PhD, Anton Trochanov, MD, Naomi V Dahl, PharmD, Julie Krop, MD

Blood (2017) 130 (Supplement 1): 3500.

https://doi.org/10.1182/blood.V130.Suppl_1.3500.3500

Published: 2017

Journal Articles

Results of the First American Prospective Study of IV Iron in Oral Iron Intolerant Iron Deficient Gravidas

Michael Auerbach, MD, Samuel Smith, MD, Stephanie James, MD

Blood (2016) 128 (22): 1277.

https://doi.org/10.1182/blood.V128.22.1277.1277

Published: 2016

Journal Articles

Safety and Efficacy of Rapid (one hour) Single Intravenous Dose Low Molecular Weight Iron Dextran for Treatment of Oral Iron Intolerant Maternal Iron Deficient Anemia

Michael Auerbach, MD, Lilee Wong, MD, Jessica McClintock, MD, Steven Lenowitz, MD, Nicola London, MD, Sarah Auerbach, BBA, Samuel Smith, MD

Blood (2015) 126 (23): 3356.

https://doi.org/10.1182/blood.V126.23.3356.3356

Published: 2015

Journal Articles

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Tahir Mehmood, MD, Khine Swe, MD, Gopimohan Das, MD, Aysegul Gozu, MD MPH, Michael Auerbach, MD, Sein Aung, MD

Blood (2014) 124 (21): 4028.

https://doi.org/10.1182/blood.V124.21.4028.4028

Published: 2014

Journal Articles

Efficacy of Total Dose Administration (TDI) of 1012 Mg of Ferumoxytol Over 15 Minutes for the Treatment of Iron Deficient Anemia

Michael Auerbach, MD, William Strauss, M.D., F.A.C.C., Sarah Auerbach, Stella Rineer, Huzefa Bahrain

Blood (2012) 120 (21): 3204.

https://doi.org/10.1182/blood.V120.21.3204.3204

Published: 2012

Journal Articles

The Safety and Efficacy of Total Dose Infusion of 1020 Mg of Ferumoxytol Administered in 15 Minutes

Michael Auerbach, MD, Stella Rineer, RN, Huzefa Bahrain, DO, Sarah A Auerbach, BA

Blood (2011) 118 (21): 1042.

https://doi.org/10.1182/blood.V118.21.1042.1042

Published: 2011

Journal Articles

Rapid (Sixty Minutes) Infusion of One Gram of Low Molecular Iron Dextran: Safety and Efficacy Profile.

Michael Auerbach, MD, Jennifer Pappadakis, Ph.D., Huzefa Bahrain, DO, Sandra Forrester, RN, OCN, Wendy Capitano, Naomi V. Dahl, Pharm.D.

Blood (2009) 114 (22): 4054.

https://doi.org/10.1182/blood.V114.22.4054.4054

Published: 2009

Journal Articles

Is Thromboembolism in Cancer Patients Treated with Erythropoietic Stimulating Agents Related to Thrombocytosis and Iron Restricted Erythropoiesis?.

David H. Henry, MD, Naomi V. Dahl, PharmD, Michael Auerbach, MD

Blood (2007) 110 (11): 1625.

https://doi.org/10.1182/blood.V110.11.1625.1625

Published: 2007

Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV CLL.

Raul R. Mena, MD, Robert Robles, MD, Michael Auerbach, MD, Mehdi M. Moezi, MD, David Headley, MD

Blood (2006) 108 (11): 4978.

https://doi.org/10.1182/blood.V108.11.4978.4978

Published: 2006

Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage III or IV, Low-Grade CLL.

Raul R. Mena, MD, Robert Robles, MD, David W. Nyman, DO, Michael Auerbach, MD, Lalita Pandit, MD

Blood (2005) 106 (11): 5045.

https://doi.org/10.1182/blood.V106.11.5045.5045

Published: 2005

Journal Articles

Intravenous Ferric Gluconate (FG) for Increasing Response to Epoetin (EPO) in Patients with Anemia of Cancer Chemotherapy - Results of a Multicenter, Randomized Trial.

David H. Henry, MD, Naomi V. Dahl, PharmD, Michael Auerbach, MD, Simon Tchekmedyian, MD, Leslie R. Laufman, MD, Ferrlecit Cancer Study Group

Blood (2004) 104 (11): 3696.

https://doi.org/10.1182/blood.V104.11.3696.3696

Published: 2004

NARROW

Measuring Reticulocyte Hemoglobin Content As a Marker for Iron Deficiency and Response to Therapy Represents a Paradigm Shift in Care

The Safety and Efficacy of Ferumoxytol in the Treatment of Iron Deficiency: A Systematic Review and Meta-Analysis

A Single Infusion of Iron Isomaltoside 1000 Allows a More Rapid Hemoglobin Increment Than Multiple Doses of Iron Sucrose with a Similar Safety Profile in Patients with Iron Deficiency Anemia

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Results of the First American Prospective Study of IV Iron in Oral Iron Intolerant Iron Deficient Gravidas

Safety and Efficacy of Rapid (one hour) Single Intravenous Dose Low Molecular Weight Iron Dextran for Treatment of Oral Iron Intolerant Maternal Iron Deficient Anemia

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Efficacy of Total Dose Administration (TDI) of 1012 Mg of Ferumoxytol Over 15 Minutes for the Treatment of Iron Deficient Anemia

The Safety and Efficacy of Total Dose Infusion of 1020 Mg of Ferumoxytol Administered in 15 Minutes

Rapid (Sixty Minutes) Infusion of One Gram of Low Molecular Iron Dextran: Safety and Efficacy Profile.

Is Thromboembolism in Cancer Patients Treated with Erythropoietic Stimulating Agents Related to Thrombocytosis and Iron Restricted Erythropoiesis?.

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV CLL.

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage III or IV, Low-Grade CLL.

Intravenous Ferric Gluconate (FG) for Increasing Response to Epoetin (EPO) in Patients with Anemia of Cancer Chemotherapy - Results of a Multicenter, Randomized Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only